NRx Pharmaceuticals, Inc. (NRXP) PT Raised to $5 at Ascendiant Capital
Tweet
Share
E-mailGet Alerts NRXP Hot Sheet
Price: $3.27 -2.1%
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Ascendiant Capital analyst Edward Woo raised the price target on NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to $5.00 (from $4.75) while maintaining a Buy rating.
You May Also Be Interested In
- H.C. Wainwright Reiterates Buy Rating on NRx Pharmaceuticals, Inc. (NRXP)
- Chemtrade Logistics Income Fund (CHE-U:CN) (CGIFF) PT Raised to Cdn$18.50 at Desjardins
- Solar Industries (SOIL:IN) PT Raised to INR23,500 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
